Loading clinical trials...
Loading clinical trials...
A Perspective, Multicenter, Open-label and Observational Trial for Unrelated Umbilical Cord Blood Stem Cell Microtransplantation Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and Secondary AML.
Conditions
Interventions
unrelated umbilical cord blood
Locations
1
China
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China
Start Date
March 1, 2022
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
October 18, 2022
NCT06303193
NCT06847867
NCT06439199
NCT07216443
NCT05588154
NCT06656494
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions